- Investing Ideas
- Chinese Pharmaceuticals & Biotech Healthy high growth potential
Chinese Pharmaceuticals & Biotech Healthy high growth potential
Results
6
Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.
6 companies
Dizal (Jiangsu) Pharmaceutical
Market Cap: CN¥24.7b
A commercial-stage biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of oncology and hematologic disorders.
688192
CN¥52.44
7D
2.5%
1Y
-29.0%
PharmaResources (Shanghai)
Market Cap: CN¥4.9b
Operates as a one-stop integrated service provider for new drug research, development, and commercial manufacturing to pharmaceutical and biotechnology companies in China and internationally.
301230
CN¥27.02
7D
19.8%
1Y
-6.3%
Chongqing Genrix Biopharmaceutical
Market Cap: CN¥8.6b
A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs in China.
688443
CN¥22.94
7D
3.8%
1Y
-30.7%
AcrobiosystemsLtd
Market Cap: CN¥9.0b
Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and research institutions.
301080
CN¥53.96
7D
13.6%
1Y
-0.02%
Zhejiang Garden BiopharmaceuticalLtd
Market Cap: CN¥7.3b
Zhejiang Garden Biopharmaceutical Co.,Ltd.
300401
CN¥13.69
7D
15.0%
1Y
-12.8%
Inner Mongolia Furui Medical Science
Market Cap: CN¥12.3b
Inner Mongolia Furui Medical Science Co., Ltd.
300049
CN¥43.07
7D
-0.9%
1Y
-12.1%